Novel Therapies Engineered to Restore Immune Tolerance
and Improve the Lives of Individuals Living with Autoimmune Diseases
About EVOQ
At EVOQ Therapeutics, we’re developing innovative immunotherapies to improve the lives of those living with autoimmune disease.
Our breakthrough NanoDisc technology targets the root cause of autoimmune disease and restores the body’s native immune tolerance in diseases like Type 1 diabetes, Celiac disease and Lupus.
EVOQ’s proprietary NanoDisc technology delivers the comprehensive coverage necessary to restore the body’s native immune tolerance.
Following simple subcutaneous administration, EVOQ NanoDiscs deliver disease-specific antigens directly to dendritic cells in the lymph nodes, liver and spleen.
This comprehensive targeting greatly enhances the desired immune response with up to 30 times greater effectiveness versus other approaches. Proven in preclinical models for diseases like Type 1 Diabetes, Multiple Sclerosis, and Lupus, our technology offers a promising new path for targeted autoimmune disease therapy with simple administration.​
Contact Us
Have questions or want to learn more about our work? We’d love to hear from you! Whether you're a potential partner, researcher, or someone interested in our therapies, we're here to connect. Reach out to us and let’s start the conversation.
Note: EVOQ Therapeutics does not send unsolicited emails or text messages. If you receive an unsolicited message from someone purporting to be from EVOQ, it is most likely a phishing scam. We would recommend you delete the message, block the sender, and of course – never provide the individual with sensitive personal information.